Accueil › Cancer de la prostate › Michigan › Detroit
Essais cliniques pour Cancer de la prostate à Detroit, MI
22 études pour Cancer de la prostate recherchent des participants dans et autour de Detroit (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
The Vanguard Study: Testing a New Way to Screen for Cancer
Recrutement en coursVolontaires sains bienvenus
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Recrutement en coursPhase 3
- Henry Ford Hospital, Detroit
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Recrutement en coursPhase 2
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Recrutement en coursPhase 3
- Henry Ford Hospital ( Site 0015), Detroit
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Recrutement en coursPhase 1/2
- Research Site, Detroit
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Recrutement en coursPhase 1
- Barbara Ann Karmanos Cancer Institute, Detroit
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Recrutement en coursPhase 3
- Karmanos Cancer Institute, Detroit
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Recrutement en coursPhase 3
- Henry Ford Hospital ( Site 0035), Detroit
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Recrutement en cours
- Wayne State University, Detroit
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Recrutement en coursPhase 3
- Henry Ford Hospital, Detroit
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Recrutement en coursPhase 1/2
- Karmanos Cancer Institute, Detroit
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Recrutement en coursPhase 3
- Wayne State University/Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Recrutement en coursPhase 1
- Karmanos, Detroit
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
Recrutement en cours
- Karmanos Cancer Institute, Detroit
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Recrutement en coursÉtude observationnelle
- Karmanos Cancer Institute, Detroit
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Recrutement en coursPhase 1/2
- Karmanos Cancer Institute, Detroit
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
Recrutement en coursPhase 1/2
- Barbara Ann Karmanos Cancer Institute, Detroit
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Recrutement en coursPhase 3
- Henry Ford Health Saint John Hospital, Detroit
A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
Recrutement en cours
- Henry Ford Health, Detroit
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- Research Site 129, Detroit
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Recrutement en coursPhase 3
- Wayne State University/Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
Essais pour Cancer de la prostate dans d'autres villes
- New York City, NY103 études
- Houston, TX76 études
- Los Angeles, CA61 études
- Boston, MA59 études
- St. Louis, MO46 études
- Chicago, IL45 études
- San Francisco, CA45 études
- Philadelphia, PA44 études
- Baltimore, MD43 études
- Nashville, TN43 études
- Seattle, WA42 études
- Washington, DC38 études
Autres études à Detroit
- Cancer du poumon non à petites cellules44 études
- Cancer du sein33 études
- Cancer (tous types)29 études
- Cancer colorectal26 études
- Cancer de l'ovaire26 études
- Cancer métastatique24 études
- Cancer de l'endomètre21 études
- Cancer du poumon20 études
- Myélome multiple19 études
- Cancer de l'estomac16 études
- Carcinome épidermoïde de la tête et du cou15 études
- Leucémie aiguë myéloïde14 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.